Scalable tobacco-cessation support for cancer survivors and their caregivers
Official title: Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers
Run by University of Florida · NCT06851936 · Data updated 2026-11-12
This project will try a tailored tobacco-cessation program plus provider training to help cancer survivors and their caregivers quit using tobacco.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 204 (estimated) |
| Sponsor | University of Florida Academic / other |
| Drugs / interventions | Radiation |
| Locations | 1 site (Gainesville, Florida) |
| Status | Recruiting |
| Started | July 11, 2025 |
| Main results expected | July 2027 |
| Study ends | August 2027 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT06851936 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult cancer survivors (including those currently in treatment) and their informal caregivers who have used any tobacco or nicotine product in the past month and receive care at participating UF Health clinics are ideal candidates.
✕Probably not a fit
People who have already quit, those who do not receive care at the participating UF clinics, or individuals unable to engage with the program activities may not receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The program combines a tailored cessation intervention for cancer survivors and their family members/caregivers who use tobacco with brief healthcare provider training in the AAC (Ask, Advise, Connect) model and C-LEAR communication skills. Patients and caregivers who report any tobacco or nicotine use in the past month and receive care in participating UF Health clinics will be enrolled. The approach is designed to integrate cessation support into oncology, urology, and radiation clinic workflows to be scalable and accessible. Outcomes will focus on engagement, quit attempts, and feasibility of broader implementation.
Why it matters
Potential benefit: If successful, the program could increase quit rates and make it easier for cancer survivors and their caregivers to get timely, tailored help to stop using tobacco.
How similar studies have gone: Prior tobacco-cessation programs and clinician training using AAC-like approaches have improved quit attempts in general populations, but scalable programs specifically tailored to cancer survivors with integrated caregiver support are relatively untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Cancer Survivors including Current Cancer Patients * Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month. * Any history of cancer diagnosis. Subjects currently receiving cancer-related treatments are eligible for enrollment. * Receiving care from the participating UF Health clinics (Medical Oncology, Urology, and Radiation Oncology). * Capable of completing study requirements * Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes * Adults aged ≥18 years Informal Caregivers/Family Members of Cancer Survivors * Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month. * A family member, informal caregiver, or friend of an enrolled cancer survivor receiving care from the participating UF Health clinics as described above * Capable of completing study requirements * Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes * Adults aged ≥18 years Exclusion Criteria: Cancer Survivors including Current Cancer Patients * Patients unable to complete the sessions because of language, travel or technology barriers * Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness. Informal Caregivers/Family Members of Cancer Survivors * Participants unable to complete the sessions because of language, travel or technology barriers * Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.
Where it's running
-
University of Florida
Gainesville, Florida, United States Recruiting
Study contacts
- Principal investigator: Jennifer LeLaurin, PhD — University of Florida
- Study coordinator: Erika Barahona, M. Ed
- Email: ebarahona@ufl.edu
- Phone: 352-273-7345
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One extra structured CBT session to help cancer patients quit smoking
This trial tests whether adding one CBT-based smoking-cessation session to standard brief counseling helps cancer patients quit smoking cigarettes.
-
Relapse-prevention counseling added to standard care for cancer patients who quit smoking at diagnosis
This trial tests whether adding one structured CBT-based relapse-prevention session helps cancer patients who have remained smoke-free since diagnosis stay abstinent longer.
-
Automating Tobacco Cessation in Primary Care
This project tests a workflow in primary care to identify smokers and help them access nicotine replacement therapy (NRT) during routine visits.
-
Text2Quit-Kenya: a mobile message program to help ED patients quit tobacco
Researchers will test a text message-based smoking-cessation program with Kenyan emergency department patients to see if it helps people quit and learn what works in this setting.
-
How people puff IQOS Iluma i vs IQOS 2.4 and how flavors feel
This study tests how exclusive IQOS users puff the newer Iluma i versus the older 2.4, and whether preferred flavor affects puffing and sensory experience.
-
Feasibility of a perinatal smoking and cannabis cessation program
This study tests a perinatal program to help pregnant people quit tobacco and cannabis and stay smoke-free after birth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.